NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced this week that it has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. The consortium brings together a group of clinical researchers from institutions in Europe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.